FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2016/04/006891 [Registered on: 28/04/2016] Trial Registered Prospectively
Last Modified On: 26/11/2019
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   "Ayurvedic management of the vision disturbance due to computer by the use of triphaladi compound and shunthyadi eye drop" 
Scientific Title of Study   "A clinical study on triphaladi compound and shunthyadi eye drops in the management of computer vision syndrome(CVS)" 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Shashi prakash gupta 
Designation  Research Scholar 
Affiliation  IPGT and RA 
Address  DEPT OF SHALAKYA TANTRA IPGT AND RA Gujarat Ayurved University JAMNAGAR
IPGT AND RA Gujarat Ayurved University JAMNAGAR 361008
Jamnagar
GUJARAT
361008
India 
Phone  9978825431  
Fax    
Email  shashiprakash.5887@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Prof Manjusha R 
Designation  Professor and HOD of Shalakya dept. 
Affiliation  IPGT and RA 
Address  DEPT OF SHALAKYA TANTRA IPGT AND RA Gujarat Ayurved University JAMNAGAR
IPGT AND RA Gujarat Ayurved University JAMNAGAR 361008
Jamnagar
GUJARAT
361008
India 
Phone  9428400759  
Fax    
Email  bhatrajma2008@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Prof Manjusha R 
Designation  Professor and HOD of Shalakya dept. 
Affiliation  IPGT and RA 
Address  DEPT OF SHALAKYA TANTRA IPGT AND RA Gujarat Ayurved University JAMNAGAR
IPGT AND RA Gujarat Ayurved University JAMNAGAR 361008
Jamnagar
GUJARAT
361008
India 
Phone  9428400759  
Fax    
Email  bhatrajma2008@gmail.com  
 
Source of Monetary or Material Support  
Institute for Post Graduate Teaching and Research in Ayurveda Gujarat Ayurved University Jamnagar – 361008 
 
Primary Sponsor  
Name  INSTITUTE FOR POST GRADUATION TEACHING AND RESEARCH IN AYURVEDA 
Address  INSTITUTE FOR POST GRADUATION TEACHING AND RESEARCH IN AYURVEDA OPP. CITY B POLICE STATION PN MARG JAMNAGAR 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Shashi prakash Gupta  IPGT and RA  Department of shalakya Opd No 4 Institute for Post Graduate Teaching and Research in Ayurveda Gujarat Ayurved University Jamnagar – 361008
Jamnagar
GUJARAT 
9978825431

shashiprakash.5887@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  computer users complaining of eye strain irritation etc ie computer vision syndrome,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Group A  Triphaladi compound orally 6gm b.d. and Shunthyadi eye drops 4times or more if required per day for 6weeks 
Comparator Agent  Group B  CMC(car boxy Methyl Cellulose)eye drops 0.5% 4times or more if required per day for 6 weeks and counseling for changing the working style and standards. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  50.00 Year(s)
Gender  Both 
Details  1. Computer users complaining of eye strain, irritation, blurred vision, redness, burning eyes, excessive tears, double vision and headache. Patients having minimum three symptoms of CVS.
2. Continuous 3hr/day and more than that exposure to any type of video display terminals(VDT) like desktop, laptop and similar devices. 
 
ExclusionCriteria 
Details  1. Patients not willing for registration.
2. Patients suffering from systemic and metabolic disorders like poly arthritis, rheumatoid arthritis, auto immune diseases, etc.
3.Use of non-specific B-blockers for longer time by glaucoma patients.
4.Patients using contact lenses.
3. Case complicated with acute/chronic infections and or inflammations of lid, conjunctiva, cornea and sclera.
 
 
Method of Generating Random Sequence   Other 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
It is expected that the trial drugs will exert a significant action over CVS(Computer Vision Syndrome).
 
6weeks
 
 
Secondary Outcome  
Outcome  TimePoints 
Significant Relief in the sign and symptoms of CVS(Computer Vision Syndrome).  6weeks 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "37"
Final Enrollment numbers achieved (India)="37" 
Phase of Trial   Phase 1 
Date of First Enrollment (India)   02/05/2016 
Date of Study Completion (India) Date Missing 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="1"
Months="7"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   No 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary
Modification(s)  
Computer vision syndrome (CVS) is such a disease, and associated mainly with improper & long standing use of computer. The American Optometric Association defines CVS as that "complex of eye and vision problems related to near work which are experienced during use of computer".
CVS is characterized by visual symptoms like eye strain, dry eyes, eye irritation, blurred vision, headache, watering of eyes, redness, double vision etc.
 
Close